子类别 專利 [0/42] 期刊論文 [141/141] 會議論文/會議摘要 [30/48] 邻近社群 伍素瑩 [52/65] 其他 [58/60] 夏克山 [76/98] 岳嶽 [29/32] 張仲明 [7/9] 張俊彥 [18/18] 張竣評 [21/26] 徐祖安 [170/215] 李秀珠 [75/105] 李靜琪 [23/24] 林書玉 [19/20] 洪明秀 [31/40] 潘秀玲(2009-2013) [16/17] 王文傑 [13/15] 王鴻俊 [7/7] 石全(2014-2017) [35/39] 童俊維 [23/23] 紀雅惠 [21/25] 翁紹華 [22/24] 莊宏 [1/1] 葉修華 [24/25] 葉燈光 [133/152] 蔣維棠 [41/66] 趙宇生(2002-2013) [120/212] 郭靜娟 [49/55] 鄒倫 [28/29] 陳志豪 [31/52] 陳新(2002-2015) [53/67] 陳炯東 [180/212] 顏婉菁 [6/7] 許明珠(1997-2001) [3/10] 陳淑貞(1998-2001) [3/11] 陳華鍵(1997-2001) [9/9] 社群统计 近3年内发表的文件:13(5.63%) 含全文笔数:171(74.03%) 文件下载次数统计 下载大于0次:171(100.00%) 下载大于100次:168(98.25%) 全文下载总次数:101952(1.90%) 最后更新时间: 2024-12-01 10:22 上传排行 数据加载中..... 下载排行 数据加载中..... 最近上传 DBPR116, a prodrug of BPRMU191, in ... Discovery of dual MER/AXL kinase in... Macrophage-mediated controlled rele... Targeting cathepsin S promotes acti... Discovery of novel AXL and MER inhi... Influence of ring strain on the for... A dual nociceptin and mu opioid rec... Development of furanopyrimidine-bas... A critical overview of current prog... Recent advances in total synthesis ...

跳至: (选择年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (选择月份) January February March April May June July August September October November December 或输入年份:

由新到旧排序 由最旧的开始

显示项目201-225 / 231. (共10页) << < 1 2 3 4 5 6 7 8 9 10 > >> 每页显示[10|25|50]项目

日期	题名	關聯
2006-06-15	Discovery of a novel family of SARS-CoV protease inhibitors by virtual screening and 3D-QSAR studies	Journal of Medicinal Chemistry. 2006 Jun;49(12):3485-3495.
2006-06-15	Substituted pyrrolidine-2,4-dicarboxylic acid amides as potent dipeptidyl peptidase IV inhibitors	Bioorganic and Medicinal Chemistry Letters. 2006 Jun;16(12):3268-3272.
2006-05-04	Structure-based drug design of a novel family of PPAR gamma partial agonists: Virtual screening, X-ray crystallography, and in vitro/in vivo biological activities	Journal of Medicinal Chemistry. 2006 May;49(9):2703-2712.
2006-05	Antitubulin agents for the treatment of cancer - a medicinal chemistry update	Expert Opinion on Therapeutic Patents. 2006 May;16(5):647-691.
2006-02-09	Indol-1-yl acetic acids as peroxisome proliferator-activated receptor agonists: Design, synthesis, structural biology, and molecular docking studies	Journal of Medicinal Chemistry. 2006 Feb;49(3):1212-1216.
2006-01-12	2-[3-[2-[(2S)-2-cyano-1-pyrrolidinyl]-2-oxoethylamino]-3-methyl-1-oxobutyl]-1,2,3,4-tetrahydroisoquinoline: A potent, selective, and orally bioavailable dipeptide-derived inhibitor of dipeptidyl peptidase IV	Journal of Medicinal Chemistry. 2006 Jan;49(1):373-380.
2006-01-01	Synthesis and anti-viral activity of a series of sesquiterpene lactones and analogues in the subgenomic HCV replicon system	Bioorganic and Medicinal Chemistry. 2006 Jan 1;14(1):83-91.
2005-12-29	Novel indole-based peroxisome proliferator-activated receptor agonists: Design, SAR, structural biology, and biological activities	Journal of Medicinal Chemistry. 2005 Dec;48(26):8194-8208.
2005-08-23	Indole compounds	US6933316B2/2005-08-23
2005-05	Shear stress inhibits smooth muscle cell-induced inflammatory gene expression in endothelial cells - Role of NF-kappa B	Arteriosclerosis, Thrombosis, and Vascular Biology. 2005 May;25(5):963-969.
2005-05	Pharmaceutical design of antimitotic agents based on combretastatins	Current Pharmaceutical Design. 2005 May;11(13):1655-1677.
2005-03	Promazine analogues as potential anti SARS-CoV drugs	Abstracts of Papers of the American Chemical Society. 2005 Mar;229(Part 2):U168.
2005-03	Design, synthesis and sar of indole-based PPAR agonists	Abstracts of Papers of the American Chemical Society. 2005 Mar;229(Part 2):U141.
2005-03	Design and structure-activity relationships of novel indole-based PPAR agonists as antidiabetic agents	Abstracts of Papers of the American Chemical Society. 2005 Mar;229(Part 2):U141.
2005	Inhibition of SARS-CoV 3C-like protease activity by theaflavin-3,3 '- digallate (TF3)	Evidence-based Complementary and Alternative Medicine. 2005;2:209-215.
2004-09-10	Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV	FEBS Letters. 2004 Sep;574(1-3):116-120.
2004-09	Drug design of BPR0L075 as an anticancer agent	World Conference on Magic Bullets - Celebrating Paul Ehrlich's 150th Birthday. 2004 Sep 9-11:Abstract # 203.
2004-08-22	Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents	Abstracts of Papers - American Chemical Society. 2004 Aug 22;228:U924.
2004-08-12	Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents	Journal of Medicinal Chemistry. 2004 Aug;47(17):4247-4257.
2004-07-15	A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells	Biochemical Pharmacology. 2004 Jul;68(2):293-303.
2004-07-01	BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo	Cancer Research. 2004 Jul;64(13):4621-4628.
2004-07	Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide	Antimicrobial Agents and Chemotherapy. 2004 Jul;48(7):2693-2696.
2004-07	Drug design for BPR0L075 as an anticancer agent	Medicine in the 21st Century Tri-Conference & Bio-Forum 2004 Shanghai International Convention Center. 2004 Jul.
2004-05-20	Synthesis and structure-activity relationships of 3-aminobenzophenones as antimitotic agents	Journal of Medicinal Chemistry. 2004 May;47(11):2897-2905.
2003-12-01	Substituent effects on di-pi-methane and aza-di-pi-methane rearrangements of dibenzo[f,h]quinoxalinobarrelenes	Tetrahedron Letters. 2003 Dec;44(49):8761-8764.

显示项目201-225 / 231. (共10页) << < 1 2 3 4 5 6 7 8 9 10 > >> 每页显示[10|25|50]项目